Hepatitis C News and Research

Latest Hepatitis C News and Research

Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons

New research identifies guidelines for prioritizing the treatment of hepatitis C infections in the U.S. prison system, resulting in a significant improvement in health outcomes of incarcerated persons while simultaneously reducing new infections in the society.

22 Mar 2019

Mayo Clinic study identifies potential new drug therapy for liver diseases

Drug therapy may effectively treat a potentially life-threatening condition associated with cirrhosis and other chronic liver diseases, according to a new study by Mayo Clinic researchers.

22 Mar 2019

NIH starts clinical trial of drug to treat cravings associated with opioid use disorder

A clinical trial of an experimental drug designed to treat cravings associated with opioid use disorder has begun in the National Institutes of Health Clinical Center.

22 Mar 2019

Many individuals recovering from addiction continue to suffer from chronic physical disease

Alcohol and other substance-use problems take enormous psychological and societal tolls on millions of Americans.

22 Mar 2019

Does it make sense to delay children’s vaccines?

When Elyse Imamura's son was an infant, she and her husband, Robert, chose to spread out his vaccinations at a more gradual pace than the official schedule recommended.

20 Mar 2019

Current HBV genome sequences help deduce ancient human population movements into Australia

Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia, adding weight to the theory that the mainland Aboriginal population separated from other early humans at least 59 thousand years ago and possibly entered the country near the Tiwi Islands.

19 Mar 2019

Researchers use big data to gain better understanding of hepatitis E virus

As far as research is concerned, hepatitis E had long led a shadowy existence - even though it is the main cause for acute viral inflammation of the liver.

18 Mar 2019

Antiviral treatment improves survival for kidney transplant recipients infected with HBV or HCV

Prior to the development of antiviral therapy, kidney transplant recipients infected with either hepatitis B or hepatitis C experienced poor outcomes.

15 Mar 2019

Shorter treatment for Chagas disease found to be effective and safer than standard treatment

A two-week treatment course for adult patients with chronic Chagas disease showed, when compared to placebo, similar efficacy and significantly fewer side effects than the standard treatment duration of eight weeks, according to the results of a clinical trial in Bolivia led by the Drugs for Neglected Diseases initiative.

14 Mar 2019

PNAS publishes results of pilot study for early detection of liver cancer

Today, Proceedings of the National Academy of Sciences published the results of a pilot study for early detection of liver cancer in a cohort of HBV carriers, who are at risk for developing this disease.

13 Mar 2019

Concurrent cuts undermine administration budget proposal

The White House budget proposal for 2020 recommends increases to the domestic HIV programs at the U.S. Centers for Disease Control and Prevention, the Health Resources and Services Administration and Indian Health Services that will be essential to keeping the administration's promise of ending our nation's HIV epidemic in the next decade.

13 Mar 2019

Many heroin users are not prepared to prevent or treat fentanyl-related overdoses, study finds

Most heroin users in Baltimore, a city heavily affected by the opioid epidemic, recognize that the heroin they buy is now almost always laced with the highly dangerous synthetic opioid fentanyl, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

6 Mar 2019

Liver tissue model can help investigate the effects of RNA interference

Novel therapies based on a process known as RNA interference hold great promise for treating a variety of diseases by blocking specific genes in a patient's cells. Many of the earliest RNAi treatments have focused on diseases of the liver, because RNA-carrying particles tend to accumulate in that organ.

6 Mar 2019

Ethan Lindenberger's vaccine debate heads to congress

Ethan Lindenberger, 18 from Norwalk, Ohio, started rebelling against his parents, like many other teenagers. The reason behind this making news is that his parents were against vaccination and he got himself inoculated against their wishes.

4 Mar 2019

Latest anti-retroviral drug therapies offer powerful solution for HIV infection-associated frailty

Treatment of the HIV/AIDS epidemic has seen remarkable advancements with the advent of the latest anti-retroviral drug therapy and powerful tools to test for drug resistance, making the infection almost "undetectable" in patients who strictly comply with their medication therapy, a just-published perspective article by a clinical team at the University of Arizona College of Medicine - Tucson points out.

27 Feb 2019

Penn researchers cure nine HCV patients following heart transplants from infected donors

Nine patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving heart transplants from deceased donors who were infected with the disease, according to a study published in the American Journal of Transplantation.

25 Feb 2019

Large-scale clinical trial begins to study liver transplantation between people with HIV

The first large-scale clinical trial to study liver transplantation between people with HIV has begun at clinical centers across the United States. The HOPE in Action Multicenter Liver Study will determine the safety of this practice by evaluating liver recipients for potential transplant-related and HIV-related complications following surgery.

15 Feb 2019

Hepatitis C News and Research

Latest Hepatitis C News and Research

Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons

Mayo Clinic study identifies potential new drug therapy for liver diseases

NIH starts clinical trial of drug to treat cravings associated with opioid use disorder

Many individuals recovering from addiction continue to suffer from chronic physical disease

Does it make sense to delay children’s vaccines?

Current HBV genome sequences help deduce ancient human population movements into Australia

Researchers use big data to gain better understanding of hepatitis E virus

Antiviral treatment improves survival for kidney transplant recipients infected with HBV or HCV

Shorter treatment for Chagas disease found to be effective and safer than standard treatment

PNAS publishes results of pilot study for early detection of liver cancer

Concurrent cuts undermine administration budget proposal

Many heroin users are not prepared to prevent or treat fentanyl-related overdoses, study finds

Liver tissue model can help investigate the effects of RNA interference

Ethan Lindenberger's vaccine debate heads to congress

Latest anti-retroviral drug therapies offer powerful solution for HIV infection-associated frailty

Penn researchers cure nine HCV patients following heart transplants from infected donors

Large-scale clinical trial begins to study liver transplantation between people with HIV

Using a health information exchange network to enhance disease surveillance

Research reveals critical immunological axis that triggers cancer-promoting chronic inflammation

Study can have implications in the vaccination policies against Hepatitis A

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in